ImpriMed ^Companies

ImpriMed is an organization that specializes in providing AI-driven precision medicine services to oncologists and pharmaceutical companies. Their main goal is to help veterinarians fight lymphoma in pets by creating individualized drug response prediction technology. This technology allows veterinary oncologists to find appropriate anticancer drugs by developing a patient-derived database for pet cancer treatment. ImpriMed's achievements include collaborating with hospitals to collect real-world clinical evidence and ordering and reporting on canine and feline lymphoma tests. They use artificial intelligence to measure how live cancer cells respond to different anticancer drugs and make personalized drug response predictions.